Therapeutic potential of lefamulin in the treatment of community-acquired pneumonia

被引：9
|
作者：
Perry, Whitney [1 ]
Golan, Yoav [1 ]
机构：
[1] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA 02111 USA
来源：
FUTURE MICROBIOLOGY | 2019年 / 14卷 / 11期
关键词：
community acquired; lefamulin; pneumonia; PLEUROMUTILIN ANTIBIOTIC BC-3781; ACUTE BACTERIAL SKIN; ANTIMICROBIAL ACTIVITY; DERIVATIVES; RESISTANCE; COMPOUND;
D O I：
10.2217/fmb-2019-0027
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Despite the increasing availability of antibiotics with activity against pathogens that cause community-acquired pneumonia (CAP), CAP remains a major cause of morbidity, hospital admissions and readmissions, and mortality. Lefamulin is a novel pleuromutilin antibiotic with potent in vitro activity against both typical and atypical CAP pathogens. In this review of the medical literature, we summarize the available information, including mounting clinical evidence, about lefamulin and its potential value in CAP.
引用
收藏
页码：927 / 939
页数：13
相关论文
共 50 条
  • [31] Community-acquired pneumonia: Diagnosis and treatment
    Sinaniotis, CA
    PEDIATRIC PULMONOLOGY, 1999, : 144 - 145
  • [32] Diagnosis and treatment of community-acquired pneumonia
    Lutfiyya, MN
    Henley, E
    Chang, LF
    Reyburn, SW
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (03) : 442 - 450
  • [33] Levofloxacin in the treatment of community-acquired pneumonia
    Léophonte, P
    Veyssier, P
    PRESSE MEDICALE, 1999, 28 (36): : 1975 - 1979
  • [34] Levofloxacin in the treatment of community-acquired pneumonia
    Noreddin, Ayman M.
    Elkhatib, Walid F.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (05) : 505 - 514
  • [35] New treatment for community-acquired pneumonia
    不详
    INFECTIONS IN MEDICINE, 2003, 20 (04) : 206 - +
  • [36] Linezolid in the treatment of community-acquired pneumonia
    Kaplan, SL
    Patterson, L
    Edwards, KM
    Azimi, PH
    Bradley, JS
    Blumer, JL
    Lobeck, FG
    Stalker, DJ
    Anderson, DC
    PEDIATRIC RESEARCH, 2000, 47 (04) : 266A - 266A
  • [37] Therapeutic efficacy of moxifloxacin in hospitalized community-acquired pneumonia
    De Benedetto, Fernando
    Del Ponte, Adriana
    Grassi, Carlo
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2010, 5 (06) : 422 - 431
  • [38] Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial
    File, Thomas M., Jr.
    Goldberg, Lisa
    Das, Anita
    Sweeney, Carolyn
    Saviski, John
    Gelone, Steven P.
    Seltzer, Elyse
    Paukner, Susanne
    Wicha, Wolfgang W.
    Talbot, George H.
    Gasink, Leanne B.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) : 1856 - 1867
  • [39] Community-acquired pneumonia
    Roaf, E
    LANCET, 1998, 352 (9145): : 2019 - 2019
  • [40] Community-Acquired Pneumonia
    Wunderink, Richard G.
    Waterer, Grant W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (06): : 543 - 551
12345